Cargando…

Promotion of hepatocellular carcinoma metastasis through matrix metalloproteinase activation by epithelial-mesenchymal transition regulator Twist1

E-cadherin loss is a key biological mechanism in tumour invasion. As a main regulator of epithelial-mesenchymal transition (EMT) mechanism-mediated invasion and metastasis, Twist1 plays an important role through its regulation of E-cadherin expression. However, whether or not Twist2 has the same fun...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhao, Xiu-lan, Sun, Tao, Che, Na, Sun, Dan, Zhao, Nan, Dong, Xue-yi, Gu, Qiang, Yao, Zhi, Sun, Bao-cun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Blackwell Publishing Ltd 2011
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3922390/ https://www.ncbi.nlm.nih.gov/pubmed/20219012 http://dx.doi.org/10.1111/j.1582-4934.2010.01052.x

Ejemplares similares

The Role of Matrix Metalloproteinases in the Epithelial-Mesenchymal Transition of Hepatocellular Carcinoma
por: Scheau, Cristian, et al.
Publicado: (2019)

Matrix Metalloproteinase-Induced Epithelial-Mesenchymal Transition in Breast Cancer
por: Radisky, Evette S., et al.
Publicado: (2010)

miR-300 inhibits epithelial to mesenchymal transition and metastasis by targeting Twist in human epithelial cancer
por: Yu, Jingshuang, et al.
Publicado: (2014)

∆9-tetrahydrocannabinol inhibits epithelial-mesenchymal transition and metastasis by targeting matrix metalloproteinase-9 in endometrial cancer
por: Zhang, Yingzhi, et al.
Publicado: (2018)

Twist1-related miR-26b-5p suppresses epithelial-mesenchymal transition, migration and invasion by targeting SMAD1 in hepatocellular carcinoma
por: Wang, Yong, et al.
Publicado: (2016)

linc-ROR facilitates hepatocellular carcinoma resistance to doxorubicin by regulating TWIST1-mediated epithelial-mesenchymal transition
por: Zhang, Yuanbiao, et al.
Publicado: (2021)

KIAA1217 Promotes Epithelial-Mesenchymal Transition and Hepatocellular Carcinoma Metastasis by Interacting with and Activating STAT3
por: Wang, Yanhong, et al.
Publicado: (2021)

Cytoplasmic p27 promotes epithelial–mesenchymal transition and tumor metastasis via STAT3-mediated Twist1 upregulation
por: Zhao, D, et al.
Publicado: (2015)

miR-214-3p inhibits epithelial-to-mesenchymal transition and metastasis of endometrial cancer cells by targeting TWIST1
por: Fang, Yuan-Yuan, et al.
Publicado: (2019)

Mesenchymal Stem Cells in Inflammation Microenvironment Accelerates Hepatocellular Carcinoma Metastasis by Inducing Epithelial-Mesenchymal Transition
por: Jing, Yingying, et al.
Publicado: (2012)

KPNA3 Confers Sorafenib Resistance to Advanced Hepatocellular Carcinoma via TWIST Regulated Epithelial-Mesenchymal Transition
por: Hu, Bo, et al.
Publicado: (2019)

Thymoquinone inhibits cancer metastasis by downregulating TWIST1 expression to reduce epithelial to mesenchymal transition
por: Khan, Md. Asaduzzaman, et al.
Publicado: (2015)

Aqueous Huaier Extract Suppresses Gastric Cancer Metastasis and Epithelial to Mesenchymal Transition by Targeting Twist
por: Xu, Zhiyuan, et al.
Publicado: (2017)

SOX5 promotes cell invasion and metastasis via activation of Twist-mediated epithelial–mesenchymal transition in gastric cancer
por: You, Jianxiong, et al.
Publicado: (2019)

Goosecoid Promotes the Metastasis of Hepatocellular Carcinoma by Modulating the Epithelial-Mesenchymal Transition
por: Xue, Tong-Chun, et al.
Publicado: (2014)

Sinomenine Hydrochloride Inhibits the Metastasis of Human Glioblastoma Cells by Suppressing the Expression of Matrix Metalloproteinase-2/-9 and Reversing the Endogenous and Exogenous Epithelial-Mesenchymal Transition
por: Jiang, Yumao, et al.
Publicado: (2018)

PTIP promotes recurrence and metastasis of hepatocellular carcinoma by regulating epithelial-mesenchymal transition
por: Leng, Shusheng, et al.
Publicado: (2017)

Matrix stiffness drives Epithelial-Mesenchymal Transition and tumour metastasis through a TWIST1-G3BP2 mechanotransduction pathway
por: Wei, Spencer C., et al.
Publicado: (2015)

Twist: A Regulator of Epithelial-Mesenchymal Transition in Lung Fibrosis
por: Pozharskaya, Veronika, et al.
Publicado: (2009)

Role of IQGAP3 in metastasis and epithelial–mesenchymal transition in human hepatocellular carcinoma
por: Shi, Yongjie, et al.
Publicado: (2017)

Architecture of epigenetic reprogramming following Twist1-mediated epithelial-mesenchymal transition
por: Malouf, Gabriel G, et al.
Publicado: (2013)

Proteinase-activated receptor 2 promotes tumor cell proliferation and metastasis by inducing epithelial-mesenchymal transition and predicts poor prognosis in hepatocellular carcinoma
por: Sun, Liang, et al.
Publicado: (2018)

Matrix metalloproteinase 2 contributes to aggressive phenotype, epithelial-mesenchymal transition and poor outcome in nasopharyngeal carcinoma
por: Li, Siyi, et al.
Publicado: (2019)

Mutant CFTR Drives TWIST1 mediated epithelial–mesenchymal transition
por: Quaresma, Margarida C., et al.
Publicado: (2020)

Membrane type 1-matrix metalloproteinase induces epithelial-to-mesenchymal transition in esophageal squamous cell carcinoma: Observations from clinical and in vitro analyses
por: Pang, Lijuan, et al.
Publicado: (2016)

Overexpression of SIRT1 promotes metastasis through epithelial-mesenchymal transition in hepatocellular carcinoma
por: Hao, Chong, et al.
Publicado: (2014)

TIP60-dependent acetylation of the SPZ1-TWIST complex promotes epithelial–mesenchymal transition and metastasis in liver cancer
por: Wang, Li-Ting, et al.
Publicado: (2018)

Higher matrix stiffness as an independent initiator triggers epithelial-mesenchymal transition and facilitates HCC metastasis
por: Dong, Yinying, et al.
Publicado: (2019)

The Expression and Functional Significance of Runx2 in Hepatocellular Carcinoma: Its Role in Vasculogenic Mimicry and Epithelial–Mesenchymal Transition
por: Cao, Zi, et al.
Publicado: (2017)

Brusatol suppresses STAT3-driven metastasis by downregulating epithelial-mesenchymal transition in hepatocellular carcinoma
por: Lee, Jong Hyun, et al.
Publicado: (2020)

MiR-195 suppresses the metastasis and epithelial–mesenchymal transition of hepatocellular carcinoma by inhibiting YAP
por: Yu, Shuo, et al.
Publicado: (2017)

TATA-box-binding protein promotes hepatocellular carcinoma metastasis through epithelial-mesenchymal transition
por: Cao, Jiayi, et al.
Publicado: (2023)

Collagen XV mediated the epithelial-mesenchymal transition to inhibit hepatocellular carcinoma metastasis
por: Yao, Ting, et al.
Publicado: (2022)

The Rho GTPase Rnd1 inhibits epithelial–mesenchymal transition in hepatocellular carcinoma and is a favorable anti-metastasis target
por: Qin, Cheng-Dong, et al.
Publicado: (2018)

Epithelial–mesenchymal transition in tumor metastasis
por: Yeung, Kay T., et al.
Publicado: (2016)

Magnesium Isoglycyrrhizinate Induces an Inhibitory Effect on Progression and Epithelial–Mesenchymal Transition of Laryngeal Cancer via the NF-κB/Twist Signaling
por: Zhang, Jiarui, et al.
Publicado: (2020)

Sox5 contributes to prostate cancer metastasis and is a master regulator of TGF-β-induced epithelial mesenchymal transition through controlling Twist1 expression
por: Hu, Jieping, et al.
Publicado: (2018)

MiR-449a suppresses the epithelial-mesenchymal transition and metastasis of hepatocellular carcinoma by multiple targets
por: Chen, Shu-peng, et al.
Publicado: (2015)

A disintegrin and metalloprotease 12 contributes to colorectal cancer metastasis by regulating epithelial-mesenchymal transition
por: Oh, Hyung-Hoon, et al.
Publicado: (2023)

Atorvastatin regulates the migration and invasion of prostate cancer through the epithelial-mesenchymal transformation and matrix metalloproteinase pathways
por: Zhu, Zhanmeng, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_3q1hp3c7i515jkenm37oenaqtr